دكتوراه / PhD

My Research about prevalence and risk factors of erectile dysfunction in male diabetic patients and using Systematic sampling technique from the AlJemaih Diabetic Center Northern State and aim at determining the magnitude and the risk factors for this proplem and contributes in the proper managment of this proplem along the sides of other aspect of diabetic complications. This study will determine the prevalence and severity of ED using the IIEF-5 and identify associated demographic, clinical, metabolic, and lifestyle factors among male diabetic patients attending AlJemaih Diabetes Center. The findings will provide baseline data for Northern State and may support earlier identification and management of ED among diabetic patients. OBJECTIVES: General Objective : To determine the prevalence and associated risk factors of ED among male patients with diabetes attending Al-Jemaih Diabetes Center, Northern State, Sudan, from August 2026 to January 2027. Specific OBJECTIVES: 1. To determine the prevalence of ED among male patients with diabetes using the IIEF-5. 2. To determine the severity of ED according to IIEF-5 scores. 3. To assess the association between ED and sociodemographic factors, including age, marital status, education, and occupation. 4. To assess the association between ED and diabetes-related factors, including diabetes type, duration, glycaemic control, treatment, and diabetic complications. 5. To assess the association between ED and clinical and lifestyle factors, including BMI, hypertension, dyslipidaemia, smoking, and physical activity. The study using a descriptive cross-sectional hospital-based study design. The minimum required sample size will therefore be 236 participants, data will be collected using a structured interviewer-administered questionnaire consisting of sections covering sociodemographic characteristics, diabetes-related characteristics, clinical factors, lifestyle factors, and erectile function. ED will be assessed using the IIEF-5. The instrument contains five questions assessing erectile confidence, erection firmness, maintenance of erection after penetration, difficulty maintaining erection until completion of intercourse, and intercourse satisfaction. The total score ranges from 5 to 25, with lower scores indicating poorer erectile function, Participants will be classified according to their total IIEF-5 score as follows: • 22–25: No ED • 17–21: Mild ED • 12–16: Mild-to-moderate ED • 8–11: Moderate ED • 5–7: Severe ED. For prevalence estimation and binary analysis, participants with an IIEF-5 score of ≤21 will be classified as having ED, while those scoring 22–25 will be classified as not having ED.

Because the questionnaire addresses sensitive sexual information, interviews will be conducted in a private setting. No participant names will be entered into the study database. Data will be coded and maintained confidentially and will be used solely for research purposes.

No risk for participants. Just data taking in a Face to Face secrete comfortable site in the diabetic Center.

The study will provide data which aid in proper managment of this proplem along the sides of other aspect of diabetic complications and filling the gab in data. No direct benefit for the participants.